封面
市场调查报告书
商品编码
1599205

全球管道切割市场:按药物、类型、患者和最终用户划分 - 2025-2030 年预测

Vasectomy Market by Drug (Anesthetics, Antibiotics, Painkillers), Type (Conventional, Minimally Invasive, No-Scalpel), Patient, End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

据预测,2023年管道切割市场价值为196.3亿美元,预计到2024年将达到211.6亿美元,复合年增长率为7.89%,到2030年将达到334.1亿美元。

输精管切除术是男性节育手术的外科手术,是切割或封闭输精管以防止精子进入射精。输精管结扎术的需求源于其作为永久性避孕方法的有效性,并为计划生育提供了可靠的解决方案。该手术主要针对寻求长期节育方法的男性。最终用途范围包括医疗机构,例如诊所、医院和进行管道切割的门诊手术中心。由于多种影响因素,例如男性避孕选择意识的提高、对有效和永久避孕方法的需求不断增长以及对计划生育共用责任的日益重视,输精管结扎术市场正在扩大。此外,微创手术技术的进步可以提高手术安全性并提高接受率和采用率。潜在的机会也存在于意识和机会仍然较低的新兴市场,为扩大教育和服务提供了机会。开拓具有成本效益、侵入性较小的手术可以吸引犹豫人群的注意力并提高市场渗透率。然而,文化阻力、某些地区认知度低以及对该程序的误解等限制可能会给市场成长带来挑战。最重要的创新在于增强技术以尽量减少恢復时间和不适,以及加强教育以降低男性对避孕方法的参与。另一个潜在的研究领域是输精管结扎术对患者的心理影响。随着越来越多的男性认识到输精管结扎术作为计划生育综合方法的一部分的好处,输精管结扎术市场的性质正在逐渐转向更广泛的接受度。投资教育宣传活动和技术进步的公司将在这个不断扩大的领域拥有竞争优势。

主要市场统计
基准年[2023] 196.3亿美元
预测年份 [2024] 211.6亿美元
预测年份 [2030] 334.1亿美元
复合年增长率(%) 7.89%

市场动态:揭示快速发展的管道切割市场的关键市场洞察

供需的动态交互作用正在改变管材切割市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,并了解消费行为及其对製造成本的影响,并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 政府不断采取措施来提高人们对管道切割的认识
    • 政府努力提高对男性节育手术的认识
  • 市场限制因素
    • 与切管手术相关的风险
  • 市场机会
    • 由于技术进步,研发活动投资增加
  • 市场挑战
    • 发展中地区的意识低落与社会禁忌

波特五力:驾驭管材切割市场的策略工具

波特的五力框架是了解管线切割市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解管道切割市场的外部影响

外部宏观环境因素对管材切割市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解管材切割市场的竞争状况

对管道切割市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵切管市场供应商绩效评估

FPNV定位矩阵是评估管材切割市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製管道切割市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对管道切割市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 政府不断努力提高人们对管道切割的认识
      • 政府努力提高对男性节育手术的认识
    • 抑制因素
      • 与切管手术相关的风险
    • 机会
      • 随着技术进步,增加投资以促进研发活动
    • 任务
      • 发展中地区的意识低落与社会禁忌
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药物切管市场

  • 麻醉剂
  • 抗生素
  • 止痛药

第七章管材切割市场:依类型

  • 传统的
  • 微创
  • 没有手术刀

第八章患者切管市场

  • 动物
  • 人类

第九章管道切割市场:依最终用户分类

  • 医院/诊所
  • 研究和学术

第十章 北美和南美管道切割市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太切管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲管道切割市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Accurate Surgical & Scientific Instruments Corporation
  • Advanced Meditech International
  • Bayer AG
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Kapp Surgical Instrument Inc.
  • McKesson Medical-Surgical Inc.
  • Novartis AG
  • PARAGON MEDICAL SUPPLY, INC.
  • Pfizer, Inc.
  • Sanofi SA
  • Sklar Surgical Instruments
  • Surtex Instruments Limited
  • Wexler Surgical, Inc.
Product Code: MRR-0307E66790F4

The Vasectomy Market was valued at USD 19.63 billion in 2023, expected to reach USD 21.16 billion in 2024, and is projected to grow at a CAGR of 7.89%, to USD 33.41 billion by 2030.

Vasectomy, a surgical procedure for male sterilization, involves cutting or sealing the vas deferens to prevent sperm from entering the ejaculate. The necessity of vasectomies arises from their effectiveness as a permanent form of contraception, providing a reliable solution for family planning. This procedure primarily finds application in men seeking long-term birth control solutions. The end-use scope encompasses healthcare facilities, including clinics, hospitals, and outpatient surgical centers, where vasectomies are performed. The market for vasectomy is expanding due to several influencing factors: increasing awareness about male contraceptive options, rising demand for effective and permanent birth control methods, and the growing emphasis on shared responsibility in family planning. Additionally, advancements in minimally invasive surgical techniques have improved the procedure's safety, potentially boosting acceptance and adoption rates. Potential opportunities exist in emerging markets where awareness and access remain lower, offering a chance to educate and expand services. Developing cost-effective, less invasive procedures may also capture the attention of hesitant demographics, enhancing market penetration. However, limitations such as cultural resistance, limited awareness in some regions, and misconceptions about the procedure can pose challenges to market growth. The most significant innovations lie in enhancing procedural techniques to minimize recovery time and discomfort, as well as increasing educational outreach to destigmatize male involvement in contraceptive methods. Another potential area of research is the psychological impact of vasectomy on patients, which can address concerns and improve satisfaction post-procedure. The nature of the vasectomy market is gradually shifting towards increasing acceptance as more men recognize its benefits as part of a comprehensive approach to family planning. Companies that invest in educational campaigns and technological advancements stand to gain a competitive edge in this expanding field.

KEY MARKET STATISTICS
Base Year [2023] USD 19.63 billion
Estimated Year [2024] USD 21.16 billion
Forecast Year [2030] USD 33.41 billion
CAGR (%) 7.89%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vasectomy Market

The Vasectomy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising government initiatives to promote awareness about the vasectomy
    • Government initiatives raising awareness about male sterilization
  • Market Restraints
    • Risk associated with vasectomy surgeries
  • Market Opportunities
    • Increased investments to boost the research and development activities along with technological advancement
  • Market Challenges
    • Limited awareness and social taboo in developing regions

Porter's Five Forces: A Strategic Tool for Navigating the Vasectomy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vasectomy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vasectomy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vasectomy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vasectomy Market

A detailed market share analysis in the Vasectomy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vasectomy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vasectomy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vasectomy Market

A strategic analysis of the Vasectomy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vasectomy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accurate Surgical & Scientific Instruments Corporation, Advanced Meditech International, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Kapp Surgical Instrument Inc., McKesson Medical-Surgical Inc., Novartis AG, PARAGON MEDICAL SUPPLY, INC., Pfizer, Inc., Sanofi S.A., Sklar Surgical Instruments, Surtex Instruments Limited, and Wexler Surgical, Inc..

Market Segmentation & Coverage

This research report categorizes the Vasectomy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug, market is studied across Anesthetics, Antibiotics, and Painkillers.
  • Based on Type, market is studied across Conventional, Minimally Invasive, and No-Scalpel.
  • Based on Patient, market is studied across Animal and Human.
  • Based on End-User, market is studied across Hospital & Clinic and Research & Academic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising government initiatives to promote awareness about the vasectomy
      • 5.1.1.2. Government initiatives raising awareness about male sterilization
    • 5.1.2. Restraints
      • 5.1.2.1. Risk associated with vasectomy surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased investments to boost the research and development activities along with technological advancement
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and social taboo in developing regions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vasectomy Market, by Drug

  • 6.1. Introduction
  • 6.2. Anesthetics
  • 6.3. Antibiotics
  • 6.4. Painkillers

7. Vasectomy Market, by Type

  • 7.1. Introduction
  • 7.2. Conventional
  • 7.3. Minimally Invasive
  • 7.4. No-Scalpel

8. Vasectomy Market, by Patient

  • 8.1. Introduction
  • 8.2. Animal
  • 8.3. Human

9. Vasectomy Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospital & Clinic
  • 9.3. Research & Academic

10. Americas Vasectomy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vasectomy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vasectomy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accurate Surgical & Scientific Instruments Corporation
  • 3. Advanced Meditech International
  • 4. Bayer AG
  • 5. Bristol Myers Squibb Company
  • 6. Eli Lilly and Company
  • 7. GlaxoSmithKline plc
  • 8. Kapp Surgical Instrument Inc.
  • 9. McKesson Medical-Surgical Inc.
  • 10. Novartis AG
  • 11. PARAGON MEDICAL SUPPLY, INC.
  • 12. Pfizer, Inc.
  • 13. Sanofi S.A.
  • 14. Sklar Surgical Instruments
  • 15. Surtex Instruments Limited
  • 16. Wexler Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. VASECTOMY MARKET RESEARCH PROCESS
  • FIGURE 2. VASECTOMY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASECTOMY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VASECTOMY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VASECTOMY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASECTOMY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASECTOMY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASECTOMY MARKET DYNAMICS
  • TABLE 7. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASECTOMY MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASECTOMY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASECTOMY MARKET SIZE, BY PAINKILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASECTOMY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASECTOMY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASECTOMY MARKET SIZE, BY NO-SCALPEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASECTOMY MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASECTOMY MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASECTOMY MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASECTOMY MARKET SIZE, BY RESEARCH & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. VASECTOMY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. VASECTOMY MARKET, FPNV POSITIONING MATRIX, 2023